SERPINB3 and hepatocellular carcinoma: SerpinB3, a serine protease inhibitor, has been reported to be undetectable in normal hepatocytes, while its expression has been found to be progressively increased in patients with chronic liver diseases [26], dysplastic nodules [27], and HCC [28,29].